Yangfeng Zhang

No.253 Mid Gongye Ave, Haizhu District
Guangzhou, 510282, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Hpv-driven rewiring of the tumor immune microenvironment through single-cell profiling informs prognosis and therapy in HNSCC.

Hpv-driven rewiring of the tumor immune microenvironment through single-cell profiling informs prognosis and therapy in HNSCC.

Journal: Oral oncology
Published: September 17, 2025

ARHGAP21 enhances metastasis in hepatocellular carcinoma by inhibiting ubiquitination of filamin A.

ARHGAP21 enhances metastasis in hepatocellular carcinoma by inhibiting ubiquitination of filamin A.

Journal: Cell death discovery
Published: August 25, 2025

EPB41L3 as a prognostic biomarker suppressing cellular malignancy and correlating with the immune microenvironment in glioma.

EPB41L3 as a prognostic biomarker suppressing cellular malignancy and correlating with the immune microenvironment in glioma.

Journal: Biochemical and biophysical research communications
Published: April 09, 2025

Unveiling the multifaceted role of the FLNC gene: implications for cancer diagnosis and prognosis.

Unveiling the multifaceted role of the FLNC gene: implications for cancer diagnosis and prognosis.

Journal: European journal of medical research
Published: January 08, 2025

Unveiling the immunological terrain of pancreatic ductal adenocarcinoma: strategies to prompt immunotherapy from Mendelian randomization.

Unveiling the immunological terrain of pancreatic ductal adenocarcinoma: strategies to prompt immunotherapy from Mendelian randomization.

Journal: Discover oncology
Published: November 19, 2024

Ammonium tetrathiomolybdate attenuates acetaminophen-induced acute liver failure by inhibiting the TRPV4/Calcium/NF-κB signaling pathway.

Ammonium tetrathiomolybdate attenuates acetaminophen-induced acute liver failure by inhibiting the TRPV4/Calcium/NF-κB signaling pathway.

Journal: Biochemical pharmacology
Published: November 16, 2024

EFNA4-enhanced deubiquitination of SLC7A11 inhibits ferroptosis in hepatocellular carcinoma.

EFNA4-enhanced deubiquitination of SLC7A11 inhibits ferroptosis in hepatocellular carcinoma.

Journal: Apoptosis : an international journal on programmed cell death
Published: November 05, 2024

The causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomization (MR).

The causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomization (MR).

Journal: Ecancermedicalscience
Published: February 19, 2024

Phosphate-to-alanine ratio and bilirubin-to-androsterone glucuronide ratio are the hub metabolites in upper gastrointestinal cancers: a Mendelian randomisation (MR) study.

Phosphate-to-alanine ratio and bilirubin-to-androsterone glucuronide ratio are the hub metabolites in upper gastrointestinal cancers: a Mendelian randomisation (MR) study.

Journal: Ecancermedicalscience
Published: February 12, 2024

EFNA5 suppresses cell proliferation and tumor metastasis in hepatoma via epithelial-to-mesenchymal transition.

EFNA5 suppresses cell proliferation and tumor metastasis in hepatoma via epithelial-to-mesenchymal transition.

Journal: Discover oncology
Published: November 01, 2023

Comparative analysis of immune checkpoint inhibitors in first-line treatment of esophageal squamous cell carcinoma: a network meta-analysis.

Comparative analysis of immune checkpoint inhibitors in first-line treatment of esophageal squamous cell carcinoma: a network meta-analysis.

Journal: Immunotherapy
Published: May 04, 2023

A Meta-analysis of Total Neoadjuvant Therapies Combining Chemoradiotherapy with Induction or Consolidated Chemotherapy for Locally Advanced Rectal Cancer.

A Meta-analysis of Total Neoadjuvant Therapies Combining Chemoradiotherapy with Induction or Consolidated Chemotherapy for Locally Advanced Rectal Cancer.

Journal: Journal of gastrointestinal cancer
Published: September 09, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026